The membrane protein of SARS‐CoV suppresses NF‐κB activation
Open Access
- 17 August 2007
- journal article
- research article
- Published by Wiley in Journal of Medical Virology
- Vol. 79 (10) , 1431-1439
- https://doi.org/10.1002/jmv.20953
Abstract
Severe acute respiratory syndrome coronavirus (SARS-CoV) infects many organs, such as lung, liver, and immune organs and causes life-threatening atypical pneumonia, SARS causes high morbidity and mortality rates. The molecular mechanism of SARS pathogenesis remains elusive. Inflammatory stimuli can activate IκB kinase (IKK) signalsome and subsequently the nuclear factor kappa B (NF-κB), which influences gene expression of cyclooxygenase-2 (Cox-2) along with other transcription factors. In this work, we found that the membrane (M) protein of SARS-CoV physically interacted with IKKβ using a co-immunoprecipitation assay (IPA). Expression of M suppressed tumor necrosis factor alpha (TNF-α) induced NF-κB activation using a luciferase reporter assay. Further investigation showed M protein suppressed Cox-2 expression using a luciferase reporter gene assay, RT-PCR and Western blot analysis. The carboxyl terminal of M protein was sufficient for the M protein function. Together, these results indicate that SARS-CoV M suppresses NF-κB activity probably through a direct interaction with IKKβ, resulting in lower Cox-2 expression. Suppression of NF-κB activity and Cox-2 expression may contribute to SARS pathogenesis. J. Med. Virol. 79:1431–1439, 2007. © Wiley-Liss, Inc.Keywords
This publication has 48 references indexed in Scilit:
- RETRACTED: Nucleocapsid protein of SARS-CoV activates the expression of cyclooxygenase-2 by binding directly to regulatory elements for nuclear factor-kappa B and CCAAT/enhancer binding proteinThe International Journal of Biochemistry & Cell Biology, 2006
- Characterization of protein–protein interactions between the nucleocapsid protein and membrane protein of the SARS coronavirusVirus Research, 2004
- Peptidoglycan Induces Nuclear Factor-κB Activation and Cyclooxygenase-2 Expression via Ras, Raf-1, and ERK in RAW 264.7 MacrophagesJournal of Biological Chemistry, 2004
- Induction of cyclooxygenase-2 in macrophages by catalase: role of NF-κB and PI3K signaling pathwaysBiochemical and Biophysical Research Communications, 2004
- COX-2 and beyond: approaches to prostaglandin inhibition in human diseaseNature Reviews Drug Discovery, 2003
- Cyclooxygenase-2—10 Years LaterThe Journal of Pharmacology and Experimental Therapeutics, 2002
- The Induction of Cyclooxygenase-2 mRNA in Macrophages Is Biphasic and Requires both CCAAT Enhancer-binding protein β (C/EBPβ) and C/EBPδ Transcription FactorsPublished by Elsevier ,2001
- NF-κB AND REL PROTEINS: Evolutionarily Conserved Mediators of Immune ResponsesAnnual Review of Immunology, 1998
- Inhibition of Nuclear Factor κB Activation by a Virus-encoded IκB-like ProteinJournal of Biological Chemistry, 1998
- Mice lacking the c-rel proto-oncogene exhibit defects in lymphocyte proliferation, humoral immunity, and interleukin-2 expression.Genes & Development, 1995